|
- Multiple sclerosis - Symptoms and causes - Mayo Clinic
People who have MS and who smoke tend to have more relapses, worse progressive disease, and worse cognitive symptoms Women are up to three times as likely as men to have relapsing-remitting MS The risk for MS in the general population is about 0 5% If a parent or sibling has MS, your risk is about twice that or about 1%
- Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
Ask your healthcare team about your MS, including your test results, treatment options and, if you like, your prognosis As you learn more about MS, you may become more confident in making treatment decisions Keep friends and family close Keeping your close relationships strong can help you deal with multiple sclerosis
- Multiple sclerosis - Care at Mayo Clinic
Mayo Clinic's MS care teams evaluate thousands of people with MS each year With a concentration on MS and vast experience, Mayo Clinic specialists are able to make accurate diagnoses and recommend effective treatments from the start Because MS is less common in children than in adults, pediatric MS can be especially hard to diagnose
- Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic
Multiple sclerosis, also called MS, is a disease in which the immune system attacks the covering surrounding the nerves in your brain and spinal cord This covering is called the myelin sheath This covering is called the myelin sheath
- Esclerosis múltiple - Síntomas y causas - Mayo Clinic
Soy el Dr Oliver Tobien, neurólogo especializado en esclerosis múltiple de Mayo Clinic En este video, abordaremos los aspectos básicos de la esclerosis múltiple
- Vitamins for MS: Do supplements make a difference?
The connection between vitamin D and MS is supported by the association with exposure to sunlight and the risk of MS There is a higher incidence and risk of MS in countries away from the equator The Recommended Dietary Allowance (RDA) for adults is 600 international units (IUs) of vitamin D a day
- Demyelinating disease: What can you do about it? - Mayo Clinic
Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system In this disease, the immune system attacks the myelin sheath or the cells that produce and maintain it The attack causes swelling, also known as inflammation, and injury to the myelin sheath
- Emerging treatments for multiple sclerosis - Mayo Clinic
Siponimod (Mayzent) was approved by the FDA in 2019 This tablet is taken orally and is approved for relapsing-remitting and secondary-progressive forms of MS Siponimod is a medicine that stops certain cells that can cause damage in MS from entering the central nervous system It also helps reduce both relapses and progression of disability
|
|
|